Effect of antiangiogenic-based treatment and systemic inflammatory factors on outcomes in patients with BRAF v600-mutated metastatic colorectal cancer: a real-world study in Spain

por Martínez-Lago, Nieves, Fernández-Montes, Ana, Covela, Marta, Brozos, Elena M., De la Cámara, Juan, Méndez Méndez, José C., Jorge-Fernández, Mónica, Cousillas Castiñeiras, Antía, Reboredo, Cristina, Arias Ron, David, Pellón Augusto, María L., González Villarroel, Paula, Graña, Begoña, Salgado Fernández, Mercedes, Carral Maseda, Alberto, Vázquez Rivera, Francisca, Candamio Folgar, Sonia, Reboredo López, Margarita
Publicado 2021

Palbociclib combined with endocrine therapy in heavily pretreated HR(+)/HER2(-) advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP)

por Manso, Luis, Hernando, Cristina, Galán, María, Oliveira, Mafalda, Cabrera, Miguel A., Bratos, Raquel, Rodríguez, César A., Ruiz-Borrego, Manuel, Blanch, Salvador, Llombart-Cussac, Antonio, Delgado-Mingorance, Juan I., Álvarez-Busto, Iñaki, Gallegos, Isabel, González-Cortijo, Lucía, Morales, Serafín, Aguirre, Elena, Hernando, Blanca A., Ballesteros, Ana, Alés-Martínez, José E., Reboredo, Cristina, Oltra, Amparo, González-Cao, María, Santisteban, Marta, Malón, Diego, Echeverría, Isabel, García-Garre, Elisa, Vega, Estela, Servitja, Sònia, Andrés, Raquel, Robles, Carlos E., López, Rafael, Galve, Elena, Echarri, María J., Legeren, Marta, Moreno, Fernando
Publicado 2020